The hype about hyper signals

Slides:



Advertisements
Similar presentations
Deriving Biological Inferences From Epidemiologic Studies.
Advertisements

 Contrast media is a substance utilized to aid in the visualization of structures and vessels not seen under normal medical imaging.  Comes in the form.
Methods Protocol: Previous studies [1, 2] have involved imaging of only a single central slice of the brain. The present study used a similar paradigm,
Cellular imaging at 3 T: Detecting Cells in Inflammation using Active Labeling with Super paramagnetic Iron oxide Azhar Hosein Faraz Medical Biophysics.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Potentially inappropriate prescribing and.
CT and MRI FINDINGS IN LOCALIZED NASOPHARYNGEAL AMYLODOSIS : A CASE REPORT I. GANZOUI, Y. AROUS, R. AOUINI, M. LANDOLSI, S. KOUKI, H. BOUJEMAA, N. BEN.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
The Dependence of the Apparent Diffusion Coefficient on Voxel Location and Calculation Method Lars Ewell 1, Naren Vijayakumar Meeting of the American.
1 Psychological Symptoms among Young Maltreated Children: Do Services Make a Difference? The research for this presentation was funded by the Administration.
Manish Chaudhary BPH, MPH
By: Assoc. Prof Dr. Mohammed Ahmed Ali. MR Contrast Media MRI contrast agents contain paramagnetic or super paramagnetic metal ions which affect the MR.
Chemistry and Imaging. Body Chemistry In order to be an effective health care professional, an individual must have an understanding of basic chemistry.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 12: Multiple and Logistic Regression Marshall University.
Cohort Study.
Consent for Research Study A study for patients with a diagnosis of liver cancer who are on the waiting list for a liver transplant Comparison of advanced.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
Measuring the Severity of Medication Discrepancies: A Community Pharmacy Perspective.
ASNR 2015 Poster# EP-19 Effect of Chemotherapy on Brain Structure and Cognition in Older Women with Breast Cancer: a Brain MRI Study 1 Bihong T. Chen MD.
Sharps injuries among radiographers: Dangers associated with opening bottles of contrast agent Professor Gill Marshall Chair of Medical Imaging Education.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
Case-Control Studies Abdualziz BinSaeed. Case-Control Studies Type of analytic study Unit of observation and analysis: Individual (not group)
Wernicke’s encephalopaty: the best way to make early diagnosis D.MACHADO* – A.BOCCHIO *– A.M.ROSANO’*- M.OGGERO*- N.MILLOZ° – G.DOVERI°– T.MELONI* *Radiology.
High Coronary Calcification Scores Predict Mortality in Pre-Dialysis CKD Patients Reference: Haas MH. The risk of death in patients with a high coronary.
Vitamin D: A New Frontier in Diabetes Management Contact Information: Background Acknowledgement Methods.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Acknowledgments Lifescan Inverness Introduction  Diabetes Mellitus is the 5 th most common cause of death in the world  Life expectancy reduced on average.
Contrast-Enhanced Neuro MRA in the NSF Era: Possible Contrast Dose Reduction with a High- Relaxivity Contrast Agent Matthew J. Kuhn, MD Department of.
Date of download: 6/26/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Atrial Tissue Fibrosis Identified.
Andrew C. McClelland and Alexander Mamourian Department of Radiology
Retrospective analysis to determine the safety of gadobenate dimeglumine (Gd-BOPTA) in pediatric subjects referred for routine diagnostic cardiovascular.
UK Hospitalizations due to Stroke in Prostate Cancer Patients
Organ dose and effective dose in Full spine Eaxamniations by EOS® Stereo-radiography with micro-dose settings. A study on anthropomorphic phantoms describing.
Exploring the Natural History of Bone Marrow Oedema Lesions in
Long-term follow up of patients with craniopharyngioma
Brain imaging prior to lung cancer resection
- Higher SBP visit-to-visit variability (SBV) has been associated
Radiology & investigation of hepatobiliary system
Gadolinium(III) Introduction to a Lanthanide MRI Contrast Agent
Instructional Objectives:
Calculation of conductive inhomogeneity in children with Cystic Fibrosis lung disease: which method works? Verger N2, Arigliani M1, Raywood E3, Duncan.
Gadobenate dimeglumine (Multihance) deposition in the dentate nucleus and globus pallidus Arian Mashhood MD PGY-4.
C MacDonald1, R Ross3, JG Houston1 Studies comparing MRI with
The Need for Competing Risks
Effect of Acute Kidney Injury on Chronic Kidney Disease Progression and Proteinuria: Initial Results from a Pilot Study Horne K1, Scott R1, Packington.
Sunday Case of the Day Physics
3. Key definitions Multi-partner training package on active TB drug safety monitoring and management (aDSM) July 2016.
Evaluating Sepsis Guidelines and Patient Outcomes
Mid-Term Review – Workpackage 3 « New methods of assessment of ReDVA using imaging techniques » E. Lancelot – 03/06/2015.
Reducing Omitted Doses through Audit
By Dr Shewikar Farrag Dr Nehad Sabry
Volume 64, Issue 6, Pages (December 2013)
Venous uptake of Tc-99m MIBI: An exploration of possible causes
Wednesday Case of the Day
Clearing the C Spine in the obtunded patient
Reducing Omitted Doses through Audit
Axial MR images in a 51-year-old woman with parkinsonism.
Expected impact – direct referral to MRI
Gadolinium Update.
Functional Neuroimaging: a window on the working human brain
Iron overload in Sickle Cell disease
Radiology & investigation of hepatobiliary system
Biomarkers as Endpoints
M. Wang, J. Wood, J. Hale, L. Petsonk, and M. Attfield
Sequential axial T1-weighted noncontrast mag-netic resonance images through the posterior fossa of a 52-year-old male with history of multiple sclerosis.
Diabetic Retinopathy Clinical Research Network
Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI Neither the.
Presentation transcript:

The hype about hyper signals L.K. Young1, E. Lancelot2, S. Matthew1, L. McCormick1, J. Weir-McCall1, J.G. Houston1,3 1Department of Cardiovascular and Diabetes Medicine, School of Medicine, University of Dundee, Dundee, 2Guerbet, Villepinte, Paris, France 3NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK Pre-clinical, tissue and retrospective image analysis studies have all suggested that there is a higher likelihood of Gadolinium retention following the administration of linear agents rather than macrocyclic. The clinical effect of these hyper intensities is still unknown, however, recent case reports, in which patients have undergone extremely high numbers of linear contrast administrations, have reported the occurrence of neurological disorders such as aphasia, decreased vigilance and difficulties with executive function5,6. Fig 3: Graph representing the number of patients found in the database who have undergone 5 or more Dotarem enhanced MRI scans since 2009. Total = 161 patients. Problem Gadolinium based contrast agents (GBCA) are used worldwide to aid Magnetic Resonance Imaging (MRI). It has been well documented that exposure to some GBCAs for patients with renal failure can result in the life threatening disease Nephrogenic Systemic Fibrosis (NSF). Since the classification of GBCAs based on NSF risk, the incidence of the disease has dropped to almost zero. More recent studies, however, have reported an association between the cumulative number of some GBCAs and hyper signal intensities in specific brain regions on unenhanced T1 weighted images even in patients with normal renal function. Evidence to date suggests this is dependent on the GBCA structure and, as of yet, the clinical significance is not fully understood. Study Aim The aim of this study is to investigate whether GBCAs, in particularly the macrocyclic gadoterate meglumine (Dotarem), are causing increases in the signal intensity of specific brain regions on unenhanced T1 weighted brain images of patients with normal renal function. Signal intensity ratios of images prior to the administration of contrast will be compared to those from images taken following multiple administrations. Further analyses will include exploring associations with the cumulative dose, time intervals between injections and any potential reversibility. Potential links to other significant adverse reactions, in particular neurological and dermatological, will also be investigated. Image analysis Following cohort selection, unenhanced T1 weighted axial brain images will be gathered from each patient. The first and last contrast enhanced image must be of the brain, however, images in between do not necessarily have to be of the brain as contrast acts on the whole body regardless of the anatomy imaged. Any patient without these images will be excluded from the study. The filtration process is shown in Fig 2a while examples of patient imaging timelines are given in Fig 2b. Using OsiriX Imaging Software regions of interest (ROI) will be placed around specific brain regions as shown in Fig 4. These will be used to calculate the signal intensity ratios (SNR): dentate nucleus (DN) to pons, DN to cerebellum, DN to background, globus pallidus (GP) to thalamus and GP to background. The difference between these SNR on the first image to the last image will be calculated and assessed for any significant deviation from zero. All image analysis will be repeated for each patient cohort. Data Cohorts Since 2009 NHS Tayside has predominantly used Dotarem, a macrocyclic, ionic chelate, for contrast enhanced MRI examinations. Information regarding each MRI examination, including contrast type and dose, is recorded in scanner specific lab books. The initial stage of the research is to compile an accurate database of all contrast enhanced MRIs that have taken place across NHS Tayside since 2009. This has been organised with the help of the Health Informatics Centre (HIC) and all information is stored in the HIC safehaven. The use of this electronic database to source patient cohorts has, thus far, not been reported in any other studies. Patients are identified for analysis if they have undergone multiple contrast enhanced MRIs and their first and last examinations are brain scans (i.e. of the scan codes MSKUH(C)/MIAMB(C)). There will be 3 cohorts; two positive groups in which patients have been exposed solely to either Dotarem or linear agents and one negative control group in which patients have undergone multiple unenhanced MRIs. Background The strong paramagnetic behavior of Gadolinium helps to reduce T1 relaxation times therefore increasing tissue contrast on MRI images. Gadolinium ions on their own are highly toxic and so they are typically chelated to an organic ligand. There are 2 ligand structures; linear and macrocyclic. The type of ligand and charge varies between all commercially available GBCAs. Macrocyclic, ionic chelates are regarded as the most thermodynamically and kinetically stable in human serum while linear, non-ionic chelates are less so1. In 2014 Kanda et al.2 observed hyper signal intensities in the dentate nucleus (DN) and globus pallidus (GP) on unenhanced T1 weighted brain images in patients with a history of multiple GBCA administrations (5 or more). Further investigation showed that the there is a linear relationship between the extent of hyper signal intensities and number of contrast MRI examinations3. Mass spectrometry studies of autopsied brain specimens linked a build-up of Gadolinium to the observed hyper intensities4. An example of hyper signal intensities is given in Fig 1. a) Fig 4: Example ROI placement. Right: Dentate nucleus, cerebellum and pons. Left: Globus pallidus and thalamus. All patients who underwent contrast enhanced MRIs Patient received solely Dotarem 1st scan is a brain scan Last scan is a brain scan Further Work Following this initial stage there are many further avenues this research will explore, such as: If there is any correlation between SNRs and the number of injections or cumulative dose; The effect of time intervals between administrations on SNRs and whether there is any evidence of reversibility; Whether Dotarem is associated with good tolerance and good diagnostic performance in paediatric patients (0 – 18yr). 29 paediatric patients who have undergone 2 or more Dotarem enhanced MRI have been identified in the database; The incidence of adverse reactions (particularly neurological and dermatological) in at risk populations such as those at risk of developing hypersensitivity reactions and those with/likely to develop impaired renal function; Potential other areas of interest to investigate GBCA accumulation e.g. liver; Novel imaging techniques e.g. susceptibility weighted imaging. b) Dotarem enhanced Brain scan A Dotarem enhanced scan 2009 2015 2010 2011 2012 2013 2014 Fig 1: Unenhanced axial T1 weighted images showing hyper signal intensities of the dentate nucleus (yellow ROI) and globus pallidus (green ROI) developing following multiple linear contrast administrations. Adapted from McDonald4. Fig 2: a) Example of the cohort selection protocol for the Dotarem cohort. b) Example timeline for a patient who has undergone 5 Dotarem administrations with a baseline brain image and a final brain image. References: 1. Frenzel, T., Lengsfeld, P., Schirmer, H., Huetter, J. & Weinmann, H.-J. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest. Radiol. 43, 817–828 (2008). 2. Kanda, T., Ishii, K., Kawaguchi, H., Kitajima, K. & Takenaka, D. High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images. Radiology 270, 834–841 (2014). 3. Errante, Y. et al. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest. Radiol. 49, 685–90(2014). 4. McDonald, R. J. et al. Intracranial Gadolinium deposition after contrast-enhanced MR imaging. Radiology 275, 772–782 (2015). 5. Miller, J. H., Hu, H. H., Pokorney, A., Cornejo, P. & Towbin, R. MRI brain signal intensity changes of a child during the course of 35 gadolinium contrast examinations. Pediatrics 136, 1637–1640 (2015). 6. Barbieri, S., Schroeder, C., Froehlich, J. M., Pasch, A. & Thoeny, H. C. High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification. Contrast Media Mol. Imaging (2016). doi:10.1002/cmmi.1683